Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies is a research paper published in JNCI Cancer Spectrum (2020). On theSindex it has a DataRank of 0. It has been cited 114 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health
Grant: 5UG1CA189974
Division of Cancer Prevention, National Cancer Institute, National Institutes of Health
Grant: 2UG1CA189873-06
NCI NIH HHS
Grant: UG1 CA189974
NCI NIH HHS
Grant: UG1 CA189873
Hope Foundation for Cancer Research